In this randonmized controlled trial, aim to compare the effectiveness of local administration of tranexamic acid and blood stopper (Ankaferd®) on cessation of bleeding in epistaxis patients.
Patients over 18 years of age with epistaxis will present to the emergency department with non-traumatic epistaxis and whose bleeding do not stop with simple external compression for 10 minutes.
Patients demonstrating hemodynamic instability
Patients with documented allergy to tranexamic acid or Ankaferd
patients with known bleeding disorders,
patients using anticoagulants,
Parallel
Blood Stopper (Ankaferd)
Drug5 ml of Ankaferd® will be sprayed through the bleeding side nostril and external nasal pressure will be performed for 10 minutes.
Cessation of bleeding
Primary outcome was definition cessation in bleeding at 10-minutes after performing local drug interventions.
Re-bleeding
The secondary outcome was a comparison of the re-bleeding rate within 24 hours in the two treatments groups.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
